Paul Battle, PA-C - Autoimmune Hepatitis (2019 Conference) (LDN, low dose naltrexone)

 

LDN 2019 Conference - Friday Morning Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Kevin - England: Cancer (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Kevin from England, takes Low Dose Naltrexone (LDN) for Chronic Hepatitis, which then developed into Hepatocellular Carcinoma.

Subscribe to Hepatitis